ANG Lifesciences India Ltd Approves Unaudited Financial Results for Quarter and Nine Months Ended 31-12-2025

Key Highlights

• ANG Lifesciences India Ltd has approved the Standalone & Consolidated Un-Audited Financial Results for the quarter and nine months ended on December 31, 2025.
• The approval was given in a Board of Directors meeting held on February 14, 2026.
• The financial results were reviewed by Khurana Sharma & Co., the Statutory Auditors of the Company.
• The revenue from operations for the nine months ended on December 31, 2025, is ₹ 6,934.33 lakhs.
• The loss before tax for the nine months ended on December 31, 2025, is ₹ 1,034.29 lakhs.